Streptomycin Sulfate

硫酸链霉素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameStreptomycin Sulfate
Drug Alias Namestreptomycine链霉素硫酸盐streptomycinumestreptomicinaStreptomycin Sulfate
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Aminoglycoside antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsOcular inflammationTuberculosis, Pulmonary
Global Approved IndicationsOcular inflammationTuberculosis, Pulmonary
Approved Indications in ChinaOcular inflammation
Original Approved Country/TerritoryN/A
Original Approved Date1946/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Jiu'An Pharmaceutical Co LtdSichuan Long March Pharmaceutical Co LtdLeshan Longmarch Medicine Industry Co Ltd
Inactive CompaniesN/A
Active IndicationsOcular inflammationTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeA07AA04J01GA01
Related LinksWikipediaDrugBankKEGG